Q2 IV Administration Sets
FDA 510(k) K213588 · Quest Medical, Inc.
510(k) numberK213588
Submission
- Device name
- Q2 IV Administration Sets
- Applicant
- Quest Medical, Inc.
Allen, TX, US - Received
- November 12, 2021
- Decision date
- June 2, 2022
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- FPA – Set, Administration, Intravascular
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 880.5440
- Specialty
- General Hospital
Other 510(k)s with product code FPA
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K254123 | Ecomed Disposable Administration SetsFPA · Abbreviated | Ecomed Solutions, LLC | 09/11/2026SE |
| K261530 | iiSure Infusion SetFPA · Special | Deka Research and Development | 06/03/2026SE |
| K252543 | AMSafe Administration Set (BA-70075, BA-70071-D, BA-70070, BA-70071-P, BA-70072…FPA · Traditional | Amsino International, Inc. | 05/04/2026SE |
| K251375 | PuraCath Firefly Needleless Connector IT (9005)FPA · Traditional | Puracath Medical, Inc. | 02/12/2026SE |
| K251257 | nSet+ Stabilization Set [6426733]; nSet+ Stabilization Set with nSyte Needle Free…FPA · Traditional | Np Medical | 12/04/2025SE |
| K250325 | BD Alaris Pump Infusion SetFPA · Traditional | Carefusion (Bd) | 10/30/2025SE |
| K251814 | EZ IV Administration SetFPA · Traditional | Epic Medical Pte. , Ltd. | 08/29/2025SE |
| K251854 | SteadiSet infusion setFPA · Abbreviated | Tandem Diabetes Care | 08/06/2025SE |
| K243841 | Sparta Infusion Set for InsulinFPA · Traditional | Deka Research and Development | 08/01/2025SE |
| K243392 | Infusomat® Space Volumetric Infusion Pump Administration SetsFPA · Traditional | B.Braun Medical, Inc. | 07/24/2025SE |
More from B.Braun Medical, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K241058 | Lyka® PORT Needle Free Access Device (4170Y)FPA · Traditional | 12/18/2024SE |
| K213846 | Q2 Blood Administration SetsFPA · Traditional | 06/05/2022SE |
| K202672 | Precision Delivery Infusion SetFPA · Traditional | 01/21/2021SE |
| K201984 | MPS 3 ND Myocardial Protection SystemDTR · Traditional | 11/20/2020SE |
| K200438 | MPS 3 Myocardial Protection SystemDTR · Traditional | 06/19/2020SE |
| K182442 | MiniGuard Arterial Safety ValveMJJ · Traditional | 11/06/2018SE |
| K173716 | MPS2 Myocardial Protection System ConsoleDTR · Traditional | 10/01/2018SE |
| K162804 | Q2 Low Pressure Power Injection Extension SetFPA · Traditional | 03/08/2017SE |
| K162304 | Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV…FPA · Traditional | 12/06/2016SE |
| K151079 | Q2 Intravenous Adminstration Sets and Extension SetsFPA · Traditional | 09/30/2015SE |
Questions and answers
When was Q2 IV Administration Sets cleared by the FDA?
Q2 IV Administration Sets (K213588) received a 510(k) decision of Substantially Equivalent on June 2, 2022, 202 days after the submission was received.
What is the product code of K213588?
The FDA product code is FPA – Set, Administration, Intravascular, a Class II (moderate risk) device regulated under 21 CFR 880.5440.